Cervical Cancer Screening
Copyright policy )Cervical Cancer Screening
Cervical cancer screening in the United States has accompanied profound decreases in cancer incidence and mortality over the last half century. Two screening strategies are currently endorsed by US-based guideline groups: (1) triennial cytology for women aged 21 to 65 years, and (2) triennial cytology for women aged 21 to 29 years followed by cytology plus testing for high-risk human papillomavirus types every 5 years for women aged 30 years and older. Providing women with affordable, easily accessible screening, follow-up of abnormal tests, and timely treatment will result in the greatest impact of screening on cervical cancer incidence and mortality.
- Duke University United States
- University of California, San Francisco United States
Cervical cancer prevention, Clinical Trials and Supportive Activities, Clinical Sciences, Uterine Cervical Neoplasms, Clinical sciences, Cervical Cancer, Clinical Research, General & Internal Medicine, Cervical cytology, Humans, Cervical cancer screening, Papillomavirus Vaccines, High-value care, Early Detection of Cancer, Cancer, screening and diagnosis, Human papillomavirus vaccination, Biomedical and Clinical Sciences, Prevention, Papillomavirus Infections, Preterm birth, Health Services, United States, Detection, Good Health and Well Being, Reproductive Medicine, Practice Guidelines as Topic, Female, 4.4 Population screening, Human papillomavirus testing, Papanicolaou Test
Cervical cancer prevention, Clinical Trials and Supportive Activities, Clinical Sciences, Uterine Cervical Neoplasms, Clinical sciences, Cervical Cancer, Clinical Research, General & Internal Medicine, Cervical cytology, Humans, Cervical cancer screening, Papillomavirus Vaccines, High-value care, Early Detection of Cancer, Cancer, screening and diagnosis, Human papillomavirus vaccination, Biomedical and Clinical Sciences, Prevention, Papillomavirus Infections, Preterm birth, Health Services, United States, Detection, Good Health and Well Being, Reproductive Medicine, Practice Guidelines as Topic, Female, 4.4 Population screening, Human papillomavirus testing, Papanicolaou Test
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).27 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!